1. |
施梦, 祝禾辰, 曹同瓦. 急性肺损伤发病机制研究进展. 中华急诊医学杂志, 2008, 17(4): 443-444.
|
2. |
Glas GJ, Van Der Sluijs KF, Schultz MJ, et al. Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J Thromb Haemost, 2013, 11(1): 17-25.
|
3. |
Czikora I, Sridhar S, Gorshkov B, et al. Protective effect of growth hormone-releasing hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction. Front Physiol, 2014, 5: 259.
|
4. |
周玲玲, 夏国际, 罗萍. 促红细胞生成素对急性肺损伤保护作用机制的研究进展. 中国呼吸与危重监护杂志, 2018, 17(1): 105-108.
|
5. |
Fouassier M, Souweine B, Sapin AF, et al. Increase in proinflammatory cytokines in peripheral blood without haemostatic changes after LPS inhalation. Thromb Res, 2009, 124(5): 584-587.
|
6. |
Russell JA. Genetics of coagulation factors in acute lung injury. Crit Care Med, 2003, 31(4 Suppl): S243-S247.
|
7. |
Anthoni C, Russell J, Wood KC, et al. Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med, 2007, 204(7): 1595-1601.
|
8. |
Borensztajn K, Peppelenbosch MP, Spek CA. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease. Trends Mol Med, 2008, 14(10): 429-440.
|
9. |
Schwientek P, Ellinghaus P, Steppan S, et al. Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support. Physiol Genomics, 2010, 42(3): 397-405.
|
10. |
Scotton CJ, Krupiczojc MA, Königshoff M, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest, 2009, 119(9): 2550-2563.
|
11. |
Bukowska A, Zacharias I, Weinert S, et al. Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue. Eur J Pharmacol, 2013, 718(1-3): 114-123.
|
12. |
Hara T, Fukuda D, Tanaka K, et al. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis, 2015, 242(2): 639-646.
|
13. |
Esmon CT. Targeting factor Xa and thrombin: impact on coagulation and beyond. Thromb Haemost, 2014, 111(4): 625-633.
|
14. |
Sparkenbaugh EM, Chantrathammachart P, Mickelson J, et al. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood, 2014, 123(11): 1747-1756.
|
15. |
Alberelli MA, De Candia E. Functional role of protease activated receptors in vascular biology. Vascul Pharmacol, 2014, 62(2): 72-81.
|
16. |
李超, 胡晋红. 以蛋白酶活化受体 2 为靶点的药物研究进展. 药学学报, 2016, 51(3): 362-366.
|
17. |
Osuga Y, Hirota Y, Yoshino O, et al. Proteinase-activated receptors in the endometrium and endometriosis. Front Biosci (Schol Ed), 2012, 4: 1201-1212.
|
18. |
Oe Y, Hayashi S, Fushima T, et al. Coagulation factor Xa and protease-activated receptor 2 as novel therapeutic targets for diabetic nephropathy. Arterioscler Thromb Vasc Biol, 2016, 36(8): 1525-1533.
|
19. |
Rohde G. Determination of rivaroxaban--a novel, oral, direct Factor Xa inhibitor--in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2008, 872(1-2): 43-50.
|
20. |
Camici GG, Steffel J, Akhmedov A, et al. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation, 2006, 114(14): 1512-1521.
|
21. |
Becker PM, Kazi AA, Wadgaonkar R, et al. Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol, 2003, 28(4): 478-484.
|
22. |
Duan YL, Learoyd J, Meliton AY, et al. Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res, 2012, 13: 4.
|
23. |
Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin- induced inflammatory lung injury. Am J Respir Crit Care Med, 2004, 169(11): 1245-1251.
|
24. |
Madoiwa S. Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC. J Intensive Care, 2015, 3: 8.
|
25. |
Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med, 2011, 364(18): 1746-1760.
|
26. |
Komarova YA, Kruse K, Mehta D, et al. Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res, 2017, 120(1): 179-206.
|